Celularity Inc. (NASDAQ:CELUW) Short Interest Update

Celularity Inc. (NASDAQ:CELUW) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 56,439 shares, an increase of 425.4% from the May 31st total of 10,742 shares. Based on an average daily trading volume, of 24,574 shares, the short-interest ratio is presently 2.3 days.

Celularity Trading Down 20.0%

NASDAQ CELUW opened at $0.00 on Friday. Celularity has a 52 week low of $0.00 and a 52 week high of $0.06. The company has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01.

Celularity Company Profile

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.